From neural signals to life-changing impact.

Neuralink is a private neurotechnology company founded in 2016 by Elon Musk and a team of eight neuroscientists and engineers. The company’s mission is to develop implantable brain–computer interfaces (BCIs) capable of decoding and stimulating neural activity to treat neurological disorders—initially targeting paralysis and vision loss—with the long-term vision of augmenting human cognition and enabling seamless symbiosis with AI. Neuralink has created a “sewing‑machine” surgical robot and ultra-thin electrode arrays, and as of 2024, has initiated FDA-approved human trials: its first implant enabled a quadriplegic patient to control a cursor and even play chess via thought alone

Neuralink is transforming medical care and human–computer interaction. With significant funding—including a recent Series E round reportedly totaling $600M–$650M, the company has the resources to advance its cutting-edge platform‍. Its early human trial success provides proof-of-concept for assistive applications, like restoring mobility and communication to paralyzed patients, while its pioneering surgical robotics and high-bandwidth implant technology chart a clear path toward scalable, high-margin future revenues. The intersection of neurotechnology, AI integration, and medical device innovation makes Neuralink uniquely positioned to lead in a nascent $100 B+ market, with potential future expansion into broader cognitive enhancement and digital symbiosis.